Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2013 16:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
May 09, 2013 16:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
April 30, 2013 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports First Quarter 2013 Financial Results

CAMBRIDGE, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
April 09, 2013 16:15 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of First Quarter 2013 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., April 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
February 25, 2013 16:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
February 15, 2013 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2012 Financial Results

CAMBRIDGE, Mass., Feb. 15, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2012. For the...
February 07, 2013 09:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
January 24, 2013 08:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
November 27, 2012 16:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST

CAMBRIDGE, Mass., Nov. 27, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
November 20, 2012 12:41 ET | Source: Momenta Pharmaceuticals

U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in "Safe-Harbor" Case

CAMBRIDGE, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...